In this interview, Illumina’s Chief Scientist, David Bentley, speaks about the 100,000 Genomes Project which could transform the way cancer patients are cared for.
Browsing: Taxonomy > Genetics
Researchers have highlighted the potential of liquid biopsy’s ability to further our understanding of why in some individuals, cancer treatments lose effectiveness.
Researchers have unearthed molecular changes along the digestive tract that could aid the development of targeted therapies.
TET-activating strategies represent an exciting new avenue for cancer management, find out more in this editorial from Epigenomics.
A novel genetic test may help identify individuals at high-risk of anal cancer.
Editor, Jade Parker recently spoke with David Adams, Wellcome Trust Sanger Institute (Cambridge, UK) about utilizing DNA sequencing of patients and genetic screens in human cells and mice to identify cancer genes and genetic interactions.
Editor Jade Parker, speaks to Peter Campbell (Wellcome Trust Sanger Institute, Cambridge, UK) to find out how he is working towards identifying the preventable causes of cancer.
Researchers have uncovered a novel method of overriding the growth promoting effects of PTEN deletion and the answer is to inhibit another tumor suppressor gene.
A commentry of brain tumors associated with Li-Fraumeni syndrome, followed by a case report of the development of a rare gliosarcoma in a Li-Fraumeni patient
This article summarizes the outcome of a randomized phase III clinical trial investigating the effect of FLT3 inhibitors to improve FTL3-mutated acute myeloid leukemia